PhD Candidate
MIT
Cambridge, Massachusetts, United States
Louis DeRidder is a Ph.D. candidate in the Harvard-MIT HST Medical Engineering and Medical Physics program. There, he is completing his thesis research with Profs. Robert Langer and Giovanni Traverso to develop a medical device to personalize the delivery of chemotherapeutics, and in another project to improve the nonviral delivery of nucleic-acid therapies. Previously, he led a project in the Kannan Lab at Johns Hopkins developing a novel dendrimer-drug conjugate for manipulating microglia from a pro-inflammatory to an anti-inflammatory phenotype for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Louis plans to become a Professor in Biological, Chemical or Biomedical Engineering, where he will perform translational medicine research with the goal of bringing innovative devices and therapies to patients with neurological and psychiatric conditions.
Disclosure information not submitted.
Artificial Intelligence and Predictive Models in Pharmaceutical Technologies
Thursday, July 11, 2024
9:00 AM - 11:00 AM CET
